English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Kingworld Medicines 1H2017 Profit Up10.1% to RMB22.1 Million; EPS Surges 20%
Aug 30, 2017 13:04 HKT
NANOBIOTIX: New Translational Data Presented at ASTRO, NCI and SITC's Immunotherapy Workshop
Jun 16, 2017 06:00 HKT
Clinical Validation Results confirm PromarkerD can predict Diabetic Kidney Disease better than any Current Measure
Jun 12, 2017 08:00 HKT
Human Heart Tissue Grown from Stem Cells Improves Drug Testing
Jun 08, 2017 10:00 HKT
NANOBIOTIX: Promising Data from Phase I/II Head and Neck Cancer Trial with NBTXR3 Presented at the American Society of Clinical Oncology's Annual Meeting
Jun 06, 2017 00:00 HKT
Research jointly led by HKBU and HKUST decoding the first deep-sea mussel genome published in Nature Ecology & Evolution
May 23, 2017 23:30 HKT
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform
May 22, 2017 11:00 HKT
Microbiome leader Professor Borody calls for a National Australian FMT Bank to fight Drug Resistant Diseases
May 19, 2017 06:00 HKT
HKBU Chinese Medicine Scholars Conduct Research in Space Life Science aboard China's Tianzhou 1
May 18, 2017 19:00 HKT
Nanobiotix Announces First Positive Human Data Showing That NBTXR3 Could Become a Backbone in Immuno-Oncology
May 18, 2017 14:00 HKT
Microbiome leader Prof. Borody at China FMT Conference calls for Investment in Faecal Transplant Clinical Trials to Fight Serious Diseases
May 16, 2017 08:00 HKT
Nanobiotix: 2016 Annual Results
Apr 29, 2017 01:00 HKT
Nanobiotix Expands Its Clinical Development in Head and Neck Cancer and Immuno-Oncology
Apr 04, 2017 14:50 HKT
Frost & Sullivan independent industry report identifies PromarkerD as the world leading test for Diabetic Kidney Disease
Mar 28, 2017 18:00 HKT
Frost & Sullivan independent industry report identifies PromarkerD as the world leading test for Diabetic Kidney Disease
Mar 27, 2017 16:00 HKT
NANOBIOTIX: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma
Mar 24, 2017 07:00 HKT
Lee's Pharm Announces 2016 Annual Results
Mar 23, 2017 17:54 HKT
PromarkerD Predictive Diagnostics for DKD to Roll-out in Asia
Mar 22, 2017 15:00 HKT
Shanghai Pharmaceuticals Releases 2016 Annual Results
Mar 21, 2017 23:50 HKT
Jacobson Pharma Announces Acquisition of 70% Interest in Hong Ning Hong
Mar 13, 2017 22:19 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: